BioCentury | Jun 11, 2020
Finance

Checkmate raises $85M series C to support new indications for TLR9 agonist

...Checkmate Pharmaceuticals Inc., joined by fellow new investors Medicxi Ventures, Omega Funds, Clough Capital Partners, Sectoral Asset Management...
...Immunotherapy of Cancer Longitude Capital Novo Holdings A/S Sofinnova Investments Inc. venBio Partners F-Prime Capital Partners Decheng Capital Medicxi Ventures Omega Funds Clough Capital Partners Sectoral Asset Management Inc. American...
BioCentury | Jun 4, 2020
Emerging Company Profile

Hayden’s fifth venture, neuro-focused Prilenia, raises $62.5M in Forbion-led A round

...early 2023. The series A provides runway to mid-2023. New investors Morningside Venture Investments and Sectoral Asset Management...
...partners: N/A Number of employees: 10-20 Funds raised: $84.5 million Investors: Forbion, Morningside Venture Investments, Sectoral Asset Management...
BioCentury | May 21, 2020
Finance

With repurposed antiviral, Atea draws $215M as it preps Phase II COVID-19 trial

...by T. Rowe Price. Existing investors including Morningside Ventures, Cormorant Asset Management, Ally Bridge Group, Sectoral Asset Management...
BioCentury | Dec 19, 2019
Financial News

Versant’s Pipeline raises $30M series B for regenerative therapies

...end, Versant-backed Pipeline Therapeutics raised $30 million in a series B led by new investor Sectoral Asset Management...
BioCentury | Sep 10, 2019
Financial News

Sept. 10 Financial Quick Takes: Qiming backs Insilico's B round; plus 10x Genomics, Aprea, Platelet, SGI-DNA, Dermavant, Karuna Labs

...greater stake in the company are KDev Group, Versant, 5AM Ventures, HealthCap, Redmile Group and Sectoral Asset Management...
BioCentury | Apr 22, 2019
Company News

Management tracks: MeiraGTx, Retrophin, Aduro

...Oxalis Capital, which she co-founded in August 2018. Before that, she was a partner at Sectoral Asset management...
BioCentury | Dec 7, 2018
Financial News

Aprea heading for Phase III with €50M series C round

...Springs Capital to its syndicate. Also participating were existing investors 5AM Ventures, Versant Ventures, HealthCap, Sectoral Asset Management...
BioCentury | Nov 30, 2018
Financial News

Aprea heading for Phase III with €50M series C round

...Springs Capital to its syndicate. Also participating were existing investors 5AM Ventures, Versant Ventures, HealthCap, Sectoral Asset Management...
BioCentury | Aug 11, 2017
Financial News

Apellis raises $60M in series E

...Crestwood, Ky.) raised $60 million in a series E round on Aug. 10 led by Sectoral Asset Management...
BioCentury | Aug 10, 2017
Financial News

Apellis raises $60M in series E

...Apellis Pharmaceuticals Inc. (Crestwood, Ky.) raised $60 million in a series E round led by Sectoral Asset Management...
Items per page:
1 - 10 of 59
BioCentury | Jun 11, 2020
Finance

Checkmate raises $85M series C to support new indications for TLR9 agonist

...Checkmate Pharmaceuticals Inc., joined by fellow new investors Medicxi Ventures, Omega Funds, Clough Capital Partners, Sectoral Asset Management...
...Immunotherapy of Cancer Longitude Capital Novo Holdings A/S Sofinnova Investments Inc. venBio Partners F-Prime Capital Partners Decheng Capital Medicxi Ventures Omega Funds Clough Capital Partners Sectoral Asset Management Inc. American...
BioCentury | Jun 4, 2020
Emerging Company Profile

Hayden’s fifth venture, neuro-focused Prilenia, raises $62.5M in Forbion-led A round

...early 2023. The series A provides runway to mid-2023. New investors Morningside Venture Investments and Sectoral Asset Management...
...partners: N/A Number of employees: 10-20 Funds raised: $84.5 million Investors: Forbion, Morningside Venture Investments, Sectoral Asset Management...
BioCentury | May 21, 2020
Finance

With repurposed antiviral, Atea draws $215M as it preps Phase II COVID-19 trial

...by T. Rowe Price. Existing investors including Morningside Ventures, Cormorant Asset Management, Ally Bridge Group, Sectoral Asset Management...
BioCentury | Dec 19, 2019
Financial News

Versant’s Pipeline raises $30M series B for regenerative therapies

...end, Versant-backed Pipeline Therapeutics raised $30 million in a series B led by new investor Sectoral Asset Management...
BioCentury | Sep 10, 2019
Financial News

Sept. 10 Financial Quick Takes: Qiming backs Insilico's B round; plus 10x Genomics, Aprea, Platelet, SGI-DNA, Dermavant, Karuna Labs

...greater stake in the company are KDev Group, Versant, 5AM Ventures, HealthCap, Redmile Group and Sectoral Asset Management...
BioCentury | Apr 22, 2019
Company News

Management tracks: MeiraGTx, Retrophin, Aduro

...Oxalis Capital, which she co-founded in August 2018. Before that, she was a partner at Sectoral Asset management...
BioCentury | Dec 7, 2018
Financial News

Aprea heading for Phase III with €50M series C round

...Springs Capital to its syndicate. Also participating were existing investors 5AM Ventures, Versant Ventures, HealthCap, Sectoral Asset Management...
BioCentury | Nov 30, 2018
Financial News

Aprea heading for Phase III with €50M series C round

...Springs Capital to its syndicate. Also participating were existing investors 5AM Ventures, Versant Ventures, HealthCap, Sectoral Asset Management...
BioCentury | Aug 11, 2017
Financial News

Apellis raises $60M in series E

...Crestwood, Ky.) raised $60 million in a series E round on Aug. 10 led by Sectoral Asset Management...
BioCentury | Aug 10, 2017
Financial News

Apellis raises $60M in series E

...Apellis Pharmaceuticals Inc. (Crestwood, Ky.) raised $60 million in a series E round led by Sectoral Asset Management...
Items per page:
1 - 10 of 59